AI-driven discovery aims to speed development, improve delivery precision, and expand therapeutic potential of Circurna’s ciRNA™ circular RNA platformHOUSTON and IRVINE, Calif., Aug. 26, 2025 (GLOBE ...

RNA-binding proteins use a dual binding mechanism involving zinc finger (ZnF) domains and intrinsically disordered regions ...

Over the last few years, scientists and entrepreneurs have flocked to developing medicines that target RNA, the genetic ...

Discover five South Korean biotechs that have received funding in recent years and are broadening R&D in various therapeutics ...

By late 2021, mRNA vaccines had saved an estimated 7.7m lives globally, including most of the 3m Americans whom the Commonwealth Fund, an American health-care charity, estimates were saved by vaccines ...

WPBF 25 goes "On the Record" on how local medical facilities are combating cancer.

In the past decade, there has been significant interest in studying the expression of our genetic code down to the level of ...

Studying the process of brain formation illuminates just how much of development is a series of tiny miracles. Only a few ...

Certain types of biochemical processes can impair the immune system’s ability to recognize and kill cancer cells. Purdue ...

Loss-of-function mutations in the CTNNB1 gene cause β-catenin deficiency, leading to CTNNB1 syndrome, a rare neurodevelopmental disorder marked by motor and cognitive impairments. Because the disease ...

Partly focused on delivery challenges that have limited the reach of RNA medicines, new biotech company Axelyf Inc. closed a $2.6 million seed round to support development of its AXL technology and to ...

This review, led by Prof. Bochen Jiang at the School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, provides a comprehensive ...